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ABSTRACT
The relative efficacy of secondary packaging on the prevention of microbial ingress into sterile medical
device trays was examined.
Sterile device trays were aseptically filled with growth medium, exposed to microbial challenge, incubated,
and inspected for growth. During microbial challenge, all package systems were subjected to a pressure
differential that simulated those experienced during distribution.
Penetration rates were significantly decreased (P = 0.01) when unlidded trays were packaged in pouches
(0/39), compared to those in cartons (37/39). Similarly, the number of colony forming units (CFU) present
was greater for unlidded trays packaged in cartons, compared to those in pouches (P = 0.03). To further
explore the efficacy of cartons as a barrier to microbial ingress, lidded trays with a single 100 μm breach
were packaged in cartons and subjected to the same methodologies; approximately 15% exhibited growth.
When compared to unlidded trays, penetration rates (P<0.0001) and number of CFU decreased (P=0.0048).
Microbial penetration was more prevalent for sterile trays packaged within cartons than in pouches. While
folding cartons are not intended to perform as sterile barriers, this suggests that microbial penetration is
more likely to occur for trays packaged within cartons than those in pouches.

1

INTRODUCTION
The US healthcare industry continues to be one
of the largest, most diverse, and fastest growing
industries in the country, and healthcare spending
continues to escalate. Total spending was $2.2
trillion in 2007, or $7,900 per person, representing
17% of the gross domestic product (GDP).
Similar rates of increase are expected over the next
decade and it is estimated that by 2017, healthcare
spending will reach $4.3 trillion, or approximately
20% of the GDP.1, 2
Although many factors contribute to the rising
cost of healthcare, one issue of significant concern
has been the prevalence of hospital/healthcareassociated infections (HAIs).3,4 HAIs are defined as
an infection that is “acquired while an individual is
a patient at a hospital that was neither present nor
incubating in the patient prior to receiving services
in the hospital (Food and Drug Administration
Amendments Act, 2007). It has been indicated
that there are nearly 1.7 million HAIs annually in
the US3 which result in costs of $5-6 billion and
nearly 100,000 deaths.6 This has led to aggressive
strategies to diagnose and treat infections, as well
as prevent infection and transmission.7 Prevention
strategies have primarily focused on the intelligent
use of antimicrobials, changes in institutional
policy, and improved hygiene techniques.8,9
Although not frequently investigated or
implicated, medical devices are also a potential
source of microbes and an important risk factor for
HAIs10,11 that should be considered in prevention
strategies. The use of invasive devices has been
linked with the most prevalent types of HAIs.12
Hence, medical devices could serve as infection
catalysts if not properly packaged to survive the
rigors of distribution and handling or designed in a
way that facilitates sterile technique.
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Package integrity, or the ability of a package
to maintain its sterile barrier throughout the
distribution process, is of paramount importance
in the medical device industry.13 More specifically,
the question of “penetration threshold”, the
smallest size defect that allows microbial
penetration, is of critical, practical relevance.14
An integrity test that fails packages that do not
present health risks may needlessly increase costs
when the package and product are destroyed
unnecessarily. Conversely, integrity tests that pass
packages containing breaches that allow microbial
penetration constitute important health risks to
patient safety. This tension of opposites is further
compounded by the fact that new integrity testers
are increasingly sensitive, finding smaller and
smaller breaches.15 In the absence of consistent,
scientifically obtained information regarding the
penetration threshold, diligent companies throw
out any package in which they find a breach.
Recalls are made based on the potential for a
breach in integrity, as opposed to a known breach
of integrity. This is a conservative, but costly,
approach.
Of additional interest is the fact that the primary
package, the package in contact with the product
(also called the sterile barrier system (SBS), is
frequently packaged inside another “secondary”
package (also called the protective package). The
secondary packaging of medical devices is varied
and commonly includes folding cartons, pouches,
and wraps. In general, the purpose of secondary
packaging is to provide physical protection for the
SBS; however, the potential role of the secondary
package as an additional barrier for microbes is
unclear.
With the ultimate goal of effectively protecting
patient safety, investigation of the relative efficacy
of secondary packages to prevent microbial ingress
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into SBSs is warranted. Surprisingly, limited
work has been done on the broad area of microbial
ingress and medical device packages,14, 16-18 and
our search of the literature exposed a broad gap
in knowledge regarding the effect of secondary
packaging on microbial penetration.

dependent on the secondary packaging only. Trays
were randomly assigned to pouches and cartons as
secondary packages (Figure 1).

OBJECTIVE
The objective was to conduct a comparative study
examining the relative efficacy of secondary
packaging (folding cartons vs. pouches) to prevent
microbial ingress into sterile medical device trays.
METHODS
The study consisted of two specific questions:
Question 1: What is the relative effect of
secondary package type on microbial penetration
of sterile medical device trays? Tested secondary
packages were:
•

a solid bleached sulfate folding carton 0.015”
manufactured on an Artios Kongsberg
Premium Line 1930 (Figure 1a),

•

and a 7.25” x 9.50” plastic pouch (100GA
biaxially oriented Nylon 0.001, 0.0007 LDPE,
0.002 HDPE coex Lot # H150978/1/A)
(Mangar Industries, Inc., New Britain, PA),
sealed on a SenCorp (Hyannis, MA) CeraTek
Model No. 24AS/1 Serial No. 06-04236 at
the following conditions: 275°F, 60 psi, 1 s
(Figure 1b).

In order to robustly test the efficacy of secondary
packaging as a microbial barrier, all medical device
trays used for Question 1 were left unlidded inside
the secondary packages. Although unrealistic, this
created an extreme condition where sterility was

Figure 1 - Unlidded trays contained in secondary
packaging, with septa: (a) carton, (b) pouch
Question 2: Given a carton as the secondary
package, does the presence of a lid affect the
microbial penetration of trays?
For this purpose, unlidded trays were compared
with lidded trays with 100 μm breaches, after both
treatments had been packaged in cartons. Trays
packaged individually within cartons were assigned
to the absence/presence of a lid and orientation, as
follows: a) unlidded trays sitting on their bottoms,
and b) lidded trays sitting on their lids with bottoms
facing up; tray bottoms contained a single 100 μm
breach. Treatment b was intended to represent a
more realistic context for the primary packaging
and, therefore, was the only treatment to contain
the 100 μm breach. Combinations of primary and
secondary packaging (the test configurations) are
henceforth referred to as “samples”.
A total of 120 samples were used to investigate
the specific Questions 1 and 2 of the study
objective. All trays were unlidded glycol modified
polyethylene terephthalate (PETG) (Perfecseal,
Mankato, MN)). Forty of the samples were
unlidded trays sealed in individual pouches, 40
were unlidded trays packaged individually in
cartons, and the remaining 40 were lidded trays
packaged individually in cartons. The latter,
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lidded trays in cartons, each contained a 100 µm
(+/- 10%) thermal laser drilled pinhole (Lenox
Laser, Glen Arm, MD) and were sealed with a
nonporous lid. An MD2420 dual-shuttle heat
sealer (Sencorp, Hyannis, MA) was used to seal
the lids, LKF-002 Paper/PE/Foil/PE/HSC die
cut lids (Amcor Flexibles, Madison, WI), to the
trays. Batch and die positions for were recorded
and sealing conditions were 300°F, 70 psi, 2.5 s.
A Teflon® impregnated fiber glass cloth (Green
Belting Industries, Ltd., Buffalo, NY) was used to
prevent scorching and burning. All pinholes were
size certified by the laser company using flow.
Holes were also confirmed and characterized
(post sealing) by the MSU team using a microflow
detection technique manufactured by ATC, Inc.
(Indianapolis, IN).
Self-sealing septa (Illinois Instruments,
Johnsburg, IL) were applied to the primary
packages (trays) and their secondary packages
(cartons or pouches) at two locations which served
as the sites for sterile growth medium injection
(septum location 1) and pressure differential
inducement (septum location 2) (Figure 1). For
the samples with lidded trays, a septum was placed
on the center of each tray lid; this eventually
aligned with a septum on the carton so that,
together, they served as the injection site for sterile
agar (hereafter referred to as septum 1). Unlidded
trays did not receive septa at this location as there
was no lidstock to hold it. Additionally, a septum
(hereafter referred to as septum 2) was placed
in a standardized location at the end of all trays;
this site served as the location for the insertion of
a needle used to remove a known volume of air,
inducing a pressure differential across the package
(Figures 1a and 1b). After application of all septa,
trays were inserted into the appropriate secondary
package (pouch or carton).
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Septa were also added to all secondary packages
(i.e. carton or pouch) at the top center (directly
above septum 1 in the case of the lidded trays),
and at the end so that they aligned with septum 2
(Figures 1 and 2). Packaged trays were shipped
to Smith & Nephew, Inc. (Memphis, TN) and
gamma sterilized by Sterigenics (West Memphis,
AR). Packages were returned to MSU after being
sterilized.
All samples were uniquely identified and
aseptically injected with sterile growth medium.
Just prior to filling each tray, septum 1 on the
secondary package was swabbed with 70%
isopropyl alcohol to prevent contamination. Trays
were injected through septum 1 with molten sterile
nutrient growth agar that was prepared by the
Media Prep Lab at Michigan State University (East
Lansing, MI). Each aliquot of agar was contained
in its own stoppered bottle; this prevented the need
to draw from the same growth medium multiple
times, minimizing the chance for unintentional
contamination. The foam bottle stoppers were
swabbed with 70% isopropyl alcohol and a 60
mL syringe outfitted with an 18 gauge needle
was pierced through each stopper to draw up 30
mL of agar. Then, the needle was changed to a
16 gauge vented needle, which was used to inject
the agar into the packaged trays through septum
1 (Figure 1). For detailed procedures regarding
microbiological techniques please reference
Severin.14
Both lidded and unlidded trays were filled from
the lid side; however, the orientation during filling
was different. Lidded trays were oriented with their
lidstock down, so that the growth medium rested
on the lid and did not contact the 100 μm hole that
had been drilled in the bottom of the tray. Unlidded
trays were filled in the opposite orientation, so that
the agar rested inside the bottom of the tray.
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After the trays were filled with agar, they were
loaded into an aerosolizing microbial challenge
chamber built by the research team14 (Figures 2 and
3) in batches of four. Their orientations remained
the same as when filled with agar; lidded trays
sat on their lids inside the cartons so that the 100
μm holes drilled in the centers of the tray bottoms
faced up and unlidded trays were positioned with
the open portions of the trays facing up inside
the secondary packages. Since the aerosolized
spray came from the top of the chamber, these
orientations were intended to induce worst-case
conditions for microbial penetration in an effort to
conservatively evaluate the relative performance
of the treatments of interest.
Syringes used to induce pressure differential
were then positioned in a racking system within
the chamber. Septum 2 on the exterior of the
secondary packages was swabbed with 70%
isopropyl alcohol and then a syringe outfitted with
an 18 gauge needles was pierced through it. This
completed setup within the chamber, which was
then closed.

Escherichia coli K-12 (ATCC Number 29181),
a gram-negative, motile, straight-rod bacterium
ranging in size from 1.1-1.5 x 2.0-6.0 μm was
aerosolized using a starting concentration of
10^6 based on work conducted by Keller.19 E.
coli K-12 was chosen for several reasons. It is
a non-pathogenic, ubiquitous microorganism
routinely used in laboratories at MSU. It is also
smaller than Bacillus subtilis, the spores of which
are commonly used in medical device microbial
challenge studies15, 20-23 and, as a result, a more
severe challenge of the sterile barrier.
For each batch of samples, the E. coli solution
was aerosolized for 15 seconds and total exposure
time in the chamber was 30 minutes. Pressure
differential was induced simultaneously for all
four trays per batch by slowly retracting the syringe
racking system built into the chamber (Figures
2 and 3). The rate of air withdrawal was held
constant by retracting the system over a one minute
period. Pressure differential has been shown to
have a significant effect on microbial penetration
of these14,18 and other similar systems.24,25 This

Figure 2 - Top view of aerosolization chamber when loaded with trays contained in cartons: (a) before inducement of pressure, (b) after inducement
of pressure by pulling the syringe racking system utilizing built-in gloves
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is of practical relevance, as pressure differentials
may be generated during the course of product
distribution, such as during the descent of an
aircraft or descent of a vehicle down a mountain
pass. The removal of 62 mL of air from the
package was intended to simulate a descent from
an altitude of approximately 8,000ft.14

Figure 4 - Unlidded tray exhibiting growth
STATISTICAL METHODS
Figure 3 - Aerosolization chamber: (a) during
aerosolization, (b) loaded with trays in pouches,
(c) loaded with trays in cartons
After exposure in the aerosol chamber,
trays were incubated at 37°C and 50% RH for
approximately 24 hours. Following the incubation
period, trays were visually examined for microbial
growth and colony counts were conducted (Figure
4). A single colony from each tray that exhibited
growth was verified as the test organism (E. coli
K-12) using an Enterotube II Identification System
for Enterobacteriaceae (Becton Dickinson, San
Jose, CA).
Of the 120 samples, usable data was obtained
from 118. Two unlidded trays, one in a pouch
and the other in a carton, were removed from the
study due to technical problems associated with
inadvertent puncture with the syringes.
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Microbial penetration in each tray was recorded
as binary (penetration: yes/no) and count response
variables (number of CFU). Each response
variable was modeled using a separate generalized
linear mixed model assuming a binomial and an
overdispersed Poisson distribution, respectively.
The linear predictor in each model included the
fixed effect of treatment (secondary package
type or level of exposure for Questions 1 and 2,
respectively), and the random effect of challenge
batch nested within treatment, in order to account
for technical replication present in the design.
Models were fitted with the GLIMMIX procedure
of SAS (SAS version 9.2, SAS Institute Inc.,
Cary, NC). The marginal log likelihood was
approximated using an adaptive Gauss-Hermite
quadrature method in order to facilitate model
convergence. Due to an extreme category problem
(quasi-complete separation of data points given by
no penetration in any of the trays assigned to the
pouch), the effect of treatment in Question 1 was
modeled as a random effect in a Bayesian-type
approach. Sensitivity analyses were performed
using starting values for the random treatment

Effect of Packaging on Microbial Penetration

variance of 1, 10, 100, 1000 and 10000. Variance
estimates and treatment differences were not
affected by the starting values considered, thus the
proposed Bayesian analysis was considered robust
and used for inference. Contrasts were used
to compare treatments. Estimated least square
means and standard errors of the probability of
penetration, as well as CFU, were reported.
RESULTS
Question 1: What is the relative effect of
secondary package type on microbial penetration
of sterile medical device trays?
None of the unlidded trays in pouches exhibited
microbial growth. In contrast, most of the unlidded
trays in cartons did (n=39).
Secondary packaging was identified to
have a significant effect on the probability of
microbial penetration when the contained medical
device trays were unlidded (P=0.01); microbial
penetration was more likely for trays packaged
within cartons than for those within pouches
(Figure 5a). The number of CFU per unlidded tray
was also significantly greater when packed within
cartons than within pouches (P = 0.03) (Figure

5b).
Question 2: Given a carton as the secondary
package, does the presence of a lid affect the
microbial penetration of trays?
Level of exposure (lidded or unlidded) affected
the probability of microbial penetration into
the trays packaged within cartons (P<0.0001).
Microbial penetration of medical device trays
inside cartons was more likely to occur with
unlidded trays compared to lidded (Figure 6a).
In addition, the presence or absence of a lid
had a significant effect on the number of CFU
(P=0.0048), such that the number of CFU that
entered trays within cartons was greater when they
were unlidded compared to lidded (Figure 6b).
DISCUSSION
This study suggests differences in both the
rates of contamination and number of CFU that
penetrated trays when pouches were compared
with cartons as secondary packages. The pouches
outperformed the cartons as effective secondary
packaging barriers to microbial ingress, as shown
with the rates of penetration and number of CFU.

Figure 5 - Estimated least square means and standard errors for: (a) probability of microbial
penetration, and (b) number of CFU for unlidded trays in pouches and cartons
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Figure 6 - Estimated least square means and standard errors of (a) probability of microbial
penetration, and (b) number of CFU for unlidded and lidded trays in cartons
These results are not surprising given the sealed
structure of the pouch, which contrasts with
the presence of unsealed crevices of the carton.
It is also notable that the microbial challenge
conditions used were intended to be substantially
more extreme than normal expected conditions of
shipment.
We acknowledge that unlidded trays are not
realistic in a medical setting; however, they were
used in this study as a control to assess microbial
ingress through secondary packages into device
trays presented under commercial conditions, as
represented by the lidded treatment for Question 2.
The lidded trays with pinhole defects experienced
microbial penetration in 15% (6/40) of the tested
trays despite the presence of the carton.
Packaged medical devices have to survive
sterilization, shipping, and handling with their
sterile barrier systems (SBSs) intact. Packaging
manufacturers and the device companies that
employ them do not consider secondary packaging
as part of the SBS or purport that they provide
microbial barrier.13 Other benefits and determents
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of secondary packaging systems also come into
consideration when making a packaging decision,
such as stacking capabilities, billboard, barrier,
and cost, among others.
Results presented in this study have direct
implications for patient safety. Due to high rates of
nosocomial infections,5,9,26 package integrity (the
ability of a package to maintain its sterile barrier)
is imperative. At the same time, a reduction in the
cost of healthcare is viewed as a national, if not
international, need.1,2 Understanding the precise
conditions in which microbial penetration occurs
and the level of benefit (protection, identification,
convenience, etc.) packaging systems afford is of
paramount importance. The rates and treatment
challenges of healthcare-associated infections, and
the potential for devices to serve as reservoirs for
microorganisms, make further study of this issue
imperative.
LIMITATIONS
The self-built tailored-approach used to address
the research questions had logistical limitations
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that caused concerns over the experimental
design. Specifically, packaged trays grouped in
batches of four were tested in a sequential manner:
first unlidded trays within pouches, then unlidded
trays within cartons, and finally, lidded trays
within cartons. This sequential order of treatment
evaluation was due to a logistical limitation of
physical adjustments that had to be made to the
racking system of the aerosolizing chamber at each
treatment switch. We acknowledge the potential
for an ordering effect to be partially confounded
with the reported treatment effects.
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